IGC Pharma, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IGC Pharma, Inc. (IGC) on November 13, 2025. The filing reports the completion of a previously disclosed asset disposition involving the Company's wholly owned subsidiary, Holi Hemp LLC.
Key Financial Metrics
The transaction resulted in the sale of equipment, inventory, and related operating assets from the Vancouver, Washington facility. The agreed-upon fair value for the transaction was approximately $2.7 million. The filing references unaudited pro forma condensed consolidated financial statements as of June 30, 2025, and for the three months ended June 30, 2025, which reflect this disposition. Specific revenue, profit, cash flow, margin, debt, or liquidity figures for the current period are not provided in this text; investors should refer to the referenced Exhibit 99.1 for detailed pro forma data.
Material Changes
- Asset Disposition: On November 13, 2025, closing conditions were satisfied, and the sale of assets to Wellness Essentials Northwest LLC was consummated.
- Transaction Value: The final fair value was approximately $2.7 million, subject to adjustments based on the auditor's valuation review and closing conditions.
Outlook, Risks, and Management Commentary
The filing confirms the successful closure of the Sale of Assets and Manufacturing Agreement dated September 29, 2025. No specific forward-looking guidance, management commentary on future strategy, or new risk factors are detailed in this specific report text beyond the completion of the transaction. The transaction is subject to the terms of the Sale Agreement filed as Exhibit 10.1.
Key Facts for Investor Verification
- Verify the final adjusted transaction value in the auditor's valuation review, as the $2.7 million figure was subject to adjustment.
- Review Exhibit 99.1 for the unaudited pro forma financial statements to understand the impact on the balance sheet and operations.
- Confirm the specific assets and liabilities transferred to Wellness Essentials Northwest LLC by reviewing the Sale Agreement (Exhibit 10.1).
- Check subsequent filings for any cash flow impacts or tax implications resulting from the $2.7 million asset sale.